VFD Part Grid,Grid for VFD Part,Electronics Controlling Grid VFD SHAOXING HUALI ELECTRONICS CO., LTD. , https://www.cnsxhuali.com
On December 22nd, China launched its first "Neurological Research Center for Artificial Intelligence" at Beijing Tiantan Hospital. During the inauguration ceremony, Professor Wang Yongjun, a renowned neurology expert and deputy director of the National Center for Clinical Research of Neurological Diseases, emphasized that AI has the potential to revolutionize the treatment and management of neurological disorders. With its unparalleled advantages in prevention, diagnosis, treatment, and rehabilitation, AI is set to bring about a transformative technological shift in this field. The establishment of this center is expected to significantly elevate the overall standards of neurological science in China and maintain the country’s leading position on the global stage.
According to reports, nerve cell damage is typically irreversible, making early detection and intervention crucial for effective treatment. However, due to the complexity of neurological diseases, challenges in accurate diagnosis, and a lack of standardized medical practices in many hospitals across China, misdiagnosis rates remain high. Additionally, there is a shortage of skilled professionals, which further complicates the situation. AI systems, through deep learning and continuous improvement, can now achieve diagnostic accuracy exceeding 95%, matching the expertise of top-level chief physicians. By integrating these systems into local hospitals, patients no longer need to travel to major cities for quality care. They can receive personalized and high-quality treatment right in their own communities, greatly reducing the burden of long waiting times and high medical costs.
Professor Wang also revealed that the center has already developed AI diagnostic tools for head MRI and CT scans. These tools are designed to detect a wide range of brain-related conditions, including brain tumors, small vessel disease, macrovascular disease, and strokes. The full-scale application of these AI diagnostic systems is scheduled to be officially launched at the Tiantan International Cerebrovascular Disease Conference in June next year. At the event, top global experts will participate in a “human-computer competition†to test the accuracy of AI in diagnosing neurological diseases.
The success of AI applications in this field relies heavily on cutting-edge deep learning technologies and the clinical expertise of leading specialists. Beijing Tiantan Hospital is one of the world’s three major centers for neurosurgical research and the only national clinical research center for neurological diseases in China. Recently, it ranked first nationally in both neurology and neurosurgery in the Chinese Academy of Medical Sciences’ hospital technology influence rankings. Every year, over 300,000 patients with complex neurological conditions are admitted, and more than 10,000 surgeries are performed annually. The hospital also houses the largest brain tissue and blood sample bank in the country, providing valuable resources for AI research and development. With the support of the National Center for Clinical Research of Neurological Diseases, the hospital has established a strong foundation for advanced AI studies.
Looking ahead, as the center continues to expand its efforts, more AI-driven applications will emerge, such as intelligent pathological analysis, AI-assisted care for patients with cerebral neuropathy, personalized treatment planning based on patient data, and rehabilitation training for limb and speech functions in neurological diseases. These innovations promise to reshape the future of neurological care and bring significant benefits to patients nationwide.